Amplify Seymour Cannabis ETF (CNBS) closed at $22.82 on October 30, 2026, down 3.6% from the previous close, on volume of 2,342 shares (30-day average 5,406).
Data as of October 30, 2026.
30-Oct-2026
No press releases found.
House bill aims to overhaul federal scheduling of drugs
Seeking Alpha News (Fri, 30-Oct 2:27 PM ET)
CNBS is an ETF investing in the fast-developing global cannabis industry. The Fund is managed by Tim Seymour, a recognized voice and experienced investor in the cannabis space. The Fund is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications, which includes: Cannabis/Hemp Plant (Pharmaceuticals/Biotechnology, Cultivation & Retail, Hemp Products and Cannabis-Infused Products), Support (Agricultural Technology, Real Estate and Commercial Services), Ancillary (Consumption Devices/Mechanisms, Investing & Finance, Technology & Media and Other Ancillary).
Amplify Seymour Cannabis ETF trades on the ARCA stock market under the symbol CNBS.
As of October 30, 2026, CNBS stock price declined to $22.82 with 2,342 million shares trading.
CNBS has a market cap of $62.47 million. This is considered a Micro Cap stock.
In the last 3 years, CNBS traded as high as $77.76 and as low as $13.96.
CNBS has underperformed the market in the last year with a return of -13.9%, while the SPY ETF gained +12.3%. In the last 3 month period, CNBS fell short of the market, returning -8.9%, while SPY returned +2.1%. However, in the most recent 2 weeks CNBS has outperformed the stock market by returning +0.3%, while SPY returned -1.0%.
CNBS support price is $23.08 and resistance is $24.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNBS shares will trade within this expected range on the day.
